A headshot of Joanne E. Schottinger, MD

Joanne E. Schottinger, MD

Associate Professor

Dr. Joanne Schottinger is a medical oncologist and hematologist who has researched, published, and presented information about the detection, treatment, and prevention of diseases and cancers. Dr. Schottinger has served on committees that explore topics such as cancer screening programs, biotechnology and emerging pharmaceuticals, lifestyle medicine, prevention, health education, and therapeutics.

Education and Training

  • BA, summa cum laude, Boston University
  • MD, Boston University School of Medicine
  • Internship and Residency, Internal Medicine, Saint Elizabeth’s Hospital
  • Fellowship, Hematology and Medical Oncology, University of California Irvine

Years

Selected Prior Positions
1984-present Medical Oncologist and Hematologist
Kaiser Permanente, Panorama City
1992-1998 Physician in Charge, Oncology Division
Kaiser Permanente, Panorama City
1994 Medical Staff President
Kaiser Permanente, Panorama City
1995-1997 Assistant Chief, Internal Medicine
Kaiser Permanente, Panorama City
199-2002 Chief of Service, Internal Medicine
Kaiser Permanente, Panorama City
2002-2016 Regional Assistant Medical Director, Quality and Clinical Analysis
Kaiser Permanente, Southern California Region

Years

Selected Honors and Awards
2002 Leon Cohen award for distinguished clinician
Panorama City Medical Center
2006 James A. Vohs Quality Award for Sleepless Nights Timely Breast Cancer Diagnosis Program
Kaiser Permanente
2011 James A. Vohs Quality Award for Oncology Electronic Record
Kaiser Permanente
2012 David M. Lawrence Safety Award for Regional Safety Net
Kaiser Permanente
2014 James A. Vohs Quality Award for Prostate Cancer Care Program
Kaiser Permanente

Selected Publications

Selected peer-reviewed research manuscripts

  • Kwan ML, Shi JM, Habel LA, Song J, Chung J, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque R. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Research and Treatment 03/2016;156(2). DOI:10.1007/s10549-016-3763-6.
  • Jensen CD, Quinn VP, Doubeni CA, Zauber AG, Levin TR, Lee JK, Schottinger JE, Marks AR, Zhao WK, Ghai NR, Lee AT, Contreras R, Quesenberry CP, Fireman BH, Corley D. 175 Colonoscopy Delay After a Positive Fecal Test and Risk of Colorectal Cancer-Related Outcomes. Gastroenterology 04/2016;150(4):S45. DOI:10.1016/S0016-5085(16)30276-1
  • Ghai NR, Schottinger JE, Contreras R, Fischer H, Lee AT, Corley D, Doubeni CA, Jensen CD, Zauber AG, Levin TR, Quinn VP. Sa1082 Colorectal Cancer Screening Outreach Targeting Members Older than 75 Years of Age. Gastroenterology 04/2016;150(4):S234. DOI: 10.1016/S0016-5085(16)30855-1
  • Doubeni CA, Corley D, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson J, Mehta SJ, Becerra T, Zhao WK, Schottinger JE, Doria-Rose VP, Levin TR, Weiss N, Fletcher R. 251 Screening Colonoscopy and the Risk of Death From Right and Left Colon Cancers. Gastroenterology 04/2016;150(4):S61. DOI:10.1016/S0016-5085(16)30325-0
  • Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac A, Chlebowski RT. Cardiovascular Disease After Aromatase Inhibitor Use 04/2016; DOI:10.1001/jamaoncol.2016.0429